EUVIMEDEUVIMED entdecken
Open Access

An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination

Ricardo da Silva Antunes iD, Alba Grifoni, April Frazier, Daniela Weiskopf, Alessandro Sette

International Immunology · 07.08.2023 · 35 (8) · 353-359

DOI: 10.1093/intimm/dxad014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, online erschienen am 06.05.2023. Verfasst von Ricardo da Silva Antunes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI); La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this brief opinion piece, we highlight our studies characterizing adaptive SARS-CoV-2 immune responses in infection and vaccination, and the ability of SARS-CoV-2-specific T cells to recognize emerging variants of concern, and the role of pre-existing cross-reactive T cells. In the context of the debate on correlates of protection, the pandemic’s progression in the past 3 years underlined the need to consider how different adaptive immune responses might differentially contribute to protection from SARS-CoV-2 infection versus COVID-19 disease. Lastly, we discuss how cross-reactive T cell responses may be useful in generating a broad adaptive immunity, recognizing different variants and viral families. Considering vaccines with broadly conserved antigens could improve preparedness for future infectious disease outbreaks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansCOVID-19 VaccinesSARS-CoV-2VaccinationAdaptive Immunity

Stichwörter der Autor:innen

T cellantibody responsescorrelates of protectionpre-existing memoryvariants

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI); La Jolla, CA 92037, USA.
  • Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA.

ORCID-Profile: Ricardo da Silva Antunes

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

da Silva Antunes, R., Grifoni, A., Frazier, A., Weiskopf, D., & Sette, A. (2023). An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination. International Immunology, 35(8), 353-359. https://doi.org/10.1093/intimm/dxad014

Vancouver

da Silva Antunes R, Grifoni A, Frazier A, Weiskopf D, Sette A. An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination. International Immunology. 2023;35(8):353-359. doi:10.1093/intimm/dxad014

BibTeX
@article{daSilvaAntunes2023,
  author = {da Silva Antunes, Ricardo and Grifoni, Alba and Frazier, April and Weiskopf, Daniela and Sette, Alessandro},
  title = {An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination},
  journal = {International Immunology},
  year = {2023},
  volume = {35},
  number = {8},
  pages = {353--359},
  doi = {10.1093/intimm/dxad014}
}
Kostenlos starten →